Irritable bowel syndrome historical perspective
Irritable bowel syndrome Microchapters
Irritable bowel syndrome historical perspective On the Web
American Roentgen Ray Society Images of Irritable bowel syndrome historical perspective
Irritable Bowel syndrome (IBS) was first mentioned in the Rocky Mountain Medical Journal in 1950. IBS was described as a psychosomatic disorder, not explained by any biochemical or structural abnormalities. Apley and Nash conducted a famous study on 1000 children in Bristol, United Kingdom and were the first to describe recurrent abdominal pain (RAP) as the predominant feature of IBS. In 1978, the first diagnostic criteria i.e. the Manning criteria was described. It did not specify any required duration for the symptoms of IBS. The subsequent criteria saw a reduction in the required duration of symptoms to facilitate early diagnosis and treatment. In Rome in 1995, an international group of gastroenterologists defined the diagnostic criteria for IBS and this was published in 1999 under the title of the Rome II criteria. This criteria underwent modification and was described as the Rome III criteria. Since June 2016, the criteria being followed is the Rome IV criteria.
- In 1950, the concept of irritable bowel syndrome (IBS) was mentioned for the first time without the recognition of any particular etiology, in the Rocky Mountain Medical Journal.
- IBS was described as a psychosomatic disorder, not explained by any biochemical or structural abnormalities. 
- In 1958, Apley and Nash conducted a study on 1000 children in Bristol, United Kingdom and were the first to describe Recurrent Abdominal Pain (RAP), as the predominant feature of IBS.
- Recurrent abdominal pain was defined as pain in the abdomen occurring over a duration of at least 3 months, with the severity enough to cause significant impairment of function.
- In 1978, the first diagnostic criteria i.e. the Manning criteria was described. It did not specify any required duration for the symptoms of IBS.
- In 1984, the Kruris criteria for IBS specified a duration of at least two years of symptoms necessary for diagnosis.
- In 1990, the Rome criteria reduced symptom duration to a period of three months to facilitate early diagnosis and intervention.
- In 1995, an international group of gastroenterologists met in Rome and defined the diagnostic criteria for IBS. IBS was not recognized in children prior to 1995 and affected children were diagnosed with recurrent abdominal pain (RAP) instead.
- In 1999, the diagnostic criteria for IBS was published under the title of the Rome II criteria.
- In 2006, the diagnostic criteria for IBS underwent modification with the reduction of symptom duration from three to two months in pediatric patients to allow for early intervention (Rome Ⅲ). Unlike the Manning criteria, incomplete sense of evacuation is not included under the Rome III criteria.
- The following are a few famous cases of IBS:
- Adolf Hitler
- John F Kennedy
- Kurt Cobain
- BROWN PW (1950). "The irritable bowel syndrome". Rocky Mt Med J. 47 (5): 343–6. PMID 15418074.
- APLEY J, NAISH N (1958). "Recurrent abdominal pains: a field survey of 1,000 school children". Arch. Dis. Child. 33 (168): 165–70. PMC 2012205. PMID 13534750.
- El-Matary W, Spray C, Sandhu B (2004). "Irritable bowel syndrome: the commonest cause of recurrent abdominal pain in children". Eur. J. Pediatr. 163 (10): 584–8. doi:10.1007/s00431-004-1503-0. PMID 15290263.
- Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, Walker LS (2006). "Childhood functional gastrointestinal disorders: child/adolescent". Gastroenterology. 130 (5): 1527–37. doi:10.1053/j.gastro.2005.08.063. PMID 16678566.
- Lacy BE, Patel NK (2017). "Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome". J Clin Med. 6 (11). doi:10.3390/jcm6110099. PMID 29072609.
- Iwańczak B, Iwańczak F (2017). "[Functional gastrointestinal disorders in children and adolescents. The Rome IV criteria]". Pol. Merkur. Lekarski (in Polish). 43 (254): 75–82. PMID 28875974.
- Ghoshal UC (2017). "Chronic constipation in Rome IV era: The Indian perspective". Indian J Gastroenterol. 36 (3): 163–173. doi:10.1007/s12664-017-0757-1. PMID 28643273.
- Ghoshal UC (2017). "Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros". J Neurogastroenterol Motil. 23 (3): 334–340. doi:10.5056/jnm17020. PMC 5503282. PMID 28672432.
- Saps M, van Tilburg MA, Lavigne JV, Miranda A, Benninga MA, Taminiau JA, Di Lorenzo C (2016). "Recommendations for pharmacological clinical trials in children with irritable bowel syndrome: the Rome foundation pediatric subcommittee on clinical trials". Neurogastroenterol. Motil. 28 (11): 1619–1631. doi:10.1111/nmo.12896. PMID 27477090.
- Dang J, Ardila-Hani A, Amichai MM, Chua K, Pimentel M (2012). "Systematic review of diagnostic criteria for IBS demonstrates poor validity and utilization of Rome III". Neurogastroenterol. Motil. 24 (9): 853–e397. doi:10.1111/j.1365-2982.2012.01943.x. PMID 22632582.
- Olden KW (2003). "The challenge of diagnosing irritable bowel syndrome". Rev Gastroenterol Disord. 3 Suppl 3: S3–11. PMID 14502111.